Efficacy of Full and Limited Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps: A Randomised Controlled Trial
Allergy · 2026-11 · 81 (11) · 3947-3961
DOI: 10.1111/all.70438 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Allergy, online erschienen am 30.07.2026. Verfasst von P Virkkula und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Rhinosinusitis, Nasal Polyps, Endoscopy, Paranasal Sinuses. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tampere Tuberculosis Foundation, The Finnish ORL-HNS Foundation, The Paulo Foundation.
Abstract (Originalsprache)
Background
Despite adequate local treatment, chronic rhinosinusitis with nasal polyps ( CRSwNP ) may remain uncontrolled and necessitate endoscopic sinus surgery ( ESS ). It remains unclear what extent of ESS is most effective. This trial compares two common surgical approaches: full and limited functional ESS ( FESS ) in patients with CRSwNP .
Methods
AirGOs Operative is a randomised, controlled trial performed in two university hospitals. Patients with a total Sino‐nasal‐outcome‐test ( SNOT ‐22) score ≥ 30, bilateral nasal polyp score ≥ 4, modified Lund‐Mackay radiological score ≥ 14, and previous surgery or systemic medication for CRSwNP were included. The primary outcome measure was the change in disease‐specific health‐related quality of life measure SNOT ‐22 between the baseline and 12‐ and 24‐month follow‐ups.
Findings
Between Oct 23, 2018 and Oct 12, 2022, 97 patients were recruited. The per protocol analysis included 47 patients in the full FESS group and 47 patients in the limited FESS group. At 12 months, the mean SNOT ‐22 score was 22.3 ( SD 15.7) in the full FESS group and 31.5 ( SD 18.8) in the limited FESS group yielding a mean difference of −9.2. At 24 months, the mean SNOT ‐22 scores were 25.3 ( SD 16.9) and 27.8 ( SD 21.6), respectively, with a mean difference of −2.5. However, the difference in change of total SNOT ‐22 scores between the groups was insignificant and did not exceed the minimal clinically important difference. Several secondary outcome measures, amongst which olfaction and polyp load, showed differences in improvement between the groups.
Interpretation
Full and limited FESS are both effective in improving HRQoL in patients with CRSwNP within 24 months. Decrease in total SNOT ‐22 scores exceeded the minimal clinically meaningful difference in both groups, but this difference was not met between the groups at 12 or 24 months. Postoperative differences between the groups in secondary outcomes may represent better inflammatory control after full FESS . Trial Registration ClinicalTrials.gov , NCT03704415. Registered on the 8th October 2018
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
- Pulmonary Diseases, Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Otorhinolaryngology and Head/Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Department of Otorhinolaryngology, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland.
- Department of Otorhinolaryngology, University of Eastern Finland and the Wellbeing Services County of North Savo, Kuopio, Finland.
ORCID-Profile: P Virkkula, J Wikstén, L Hafrén, P Kauppi, S Toppila-Salmi
Förderung
- Tampere Tuberculosis Foundation
- The Finnish ORL-HNS Foundation
- The Paulo Foundation
- The Ahokas Foundation
- The Finnish Society of Allergology and Immunology
- The Foudation of the Finnish Anti-Tuberculosis Association
- State funding of university level health research
- The Finnish Rhinology Foundation
Zitieren
APA
Virkkula, P., Hammarén-Malmi, S., Laulajainen-Hongisto, A., Lilja, M., Wikstén, J., Hafrén, L., Kauppi, P., Reitsma, S., Pajala, K., Sahlman, J., & Toppila-Salmi, S. (2026). Efficacy of Full and Limited Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps: A Randomised Controlled Trial. Allergy, 81(11), 3947-3961. https://doi.org/10.1111/all.70438
Vancouver
Virkkula P, Hammarén-Malmi S, Laulajainen-Hongisto A, Lilja M, Wikstén J, Hafrén L, et al. Efficacy of Full and Limited Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps: A Randomised Controlled Trial. Allergy. 2026;81(11):3947-3961. doi:10.1111/all.70438
BibTeX
@article{Virkkula2026,
author = {Virkkula, P and Hammarén-Malmi, S and Laulajainen-Hongisto, A and Lilja, M and Wikstén, J and Hafrén, L and Kauppi, P and Reitsma, S and Pajala, K and Sahlman, J and Toppila-Salmi, S},
title = {Efficacy of Full and Limited Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps: A Randomised Controlled Trial},
journal = {Allergy},
year = {2026},
volume = {81},
number = {11},
pages = {3947--3961},
doi = {10.1111/all.70438}
}
EUVIMED